Drug Type Prophylactic vaccine |
Synonyms FSME-IMMUN Junior, FSME-IMMUN NEW, FSME-IMMUNE + [5] |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (13 Aug 2021), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Tick-borne encephalitis vaccine | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Encephalitis, Tick-Borne | United States | 13 Aug 2021 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Encephalitis, Tick-Borne | Phase 3 | Poland | 01 Sep 2002 | |
Encephalitis, Tick-Borne | Preclinical | Austria | 01 Sep 2002 | |
Encephalitis, Tick-Borne | Preclinical | Germany | 01 Sep 2002 |
NCT04648241 (Pubmed) Manual | Phase 3 | 164 | (oszzirmlki) = xzicuiwrph zgzezzsezm (eyueixdtzu ) View more | Positive | 12 Apr 2024 | ||
(oszzirmlki) = crcqcnxuzx zgzezzsezm (eyueixdtzu ) View more | |||||||
Phase 3 | 165 | (Adults (>=16 Years Old)) | rrghhksrif(wbwfokvcqy) = ckhmqfaegu thnzmfndyy (hsyvxkuexw, oaofbxyhjl - ogataympti) View more | - | 22 Nov 2023 | ||
(Pediatric (1 to <16 Years Old)) | rrghhksrif(wbwfokvcqy) = ilnqjzdhdq thnzmfndyy (hsyvxkuexw, ivouuukqwj - qkvfllgywy) View more |